Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity
SGA patients have an impaired glucose-insulin metabolism similar to that of children with obesity, which worsens under GH therapy. Close metabolic monitoring of GH-treated SGA patients is recommended.
Authors
- Anette Stoltze
- Wieland Kiess
- Christoph Beger (ORCID: https://orcid.org/0000-0002-1166-0368)
- E. Wenzel (ORCID: https://orcid.org/0000-0003-2814-5634)
- Ruth Gausche (ORCID: https://orcid.org/0000-0001-5809-6330)
- Robert Stein (ORCID: https://orcid.org/0000-0003-0896-9943)
- Roland Pfäffle (ORCID: https://orcid.org/0000-0001-6754-3681)
- A Körner
- Lea Prengemann
- Mandy Vogel
Institutions
- Helmholtz Centre for Environmental Research (DE)
- Leipzig University of Applied Sciences (DE)
- University Hospital Leipzig (DE)
- German Centre for Cardiovascular Research (DE)
- Life University (US)
- Leipzig University (DE)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1210/clinem/dgaf672
- Primary Topic
- Birth, Development, and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00